About
RespiQ is a health technology startup based in the Netherlands, founded in 2019. The company focuses on empowering individuals to manage their health through early detection of health issues. RespiQ has developed a non-invasive, handheld breath analyzer that measures disease biomarkers in exhaled breath. This device helps identify and monitor various health conditions, including chronic respiratory diseases, cancer, diabetes, and digestive health issues. The core innovation of RespiQ is its breath testing technology, which utilizes a proprietary algorithm to analyze a digital "breathprint" from the chemical elements in breath. This allows for accurate and cost-effective health monitoring at home or in clinical settings. Users receive personalized health insights through an intuitive app, enabling proactive management of their health status. RespiQ aims to support both patients and healthcare providers by facilitating remote monitoring and timely intervention, particularly for chronic diseases like COPD.
Technologies
Keywords
Company Information
- Employees7
- Founded2019
- Total Funding$4364560
Location
70 Langegracht, Leiden, Zuid-Holland, Netherlands, 2312 NV
